Rhythm Pharmaceuticals buy JPMorgan Chase & Co.
Start price
27.07.26
/
50%
€90.00
Target price
27.07.27
€127.17
Performance (%)
5.00%
Price
06.08.26
€94.50
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ shows slight gains of 5.00%. This prediction currently runs until 27.07.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Rhythm Pharmaceuticals | 10.526% |
| iShares Core DAX® | 2.573% |
| iShares Nasdaq 100 | 4.858% |
| iShares Nikkei 225® | 5.590% |
| iShares S&P 500 | 3.250% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating and a $145.00 price target on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€100.00
07.08.26
07.08.26
€126.70
07.08.27
07.08.27
0.00%
06.08.26
06.08.26

